Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 49,573,510 $ 139,220,208
Marketable securities 120,795,235 39,543,820
Prepaid research and development 514,910 1,001,993
Prepaid expenses and other current assets 1,292,813 343,374
Total current assets 172,176,468 180,109,395
Prepaid research and development, noncurrent 1,000,000 1,000,000
Other assets 155,759 95,121
Total assets 173,332,227 181,204,516
Current liabilities:    
Accounts payable 1,587,305 1,158,054
Accrued expenses and other current liabilities 4,124,654 4,081,282
Contingent consideration liability 0 3,061,501
Total current liabilities 5,711,959 8,300,837
Total liabilities 5,711,959 8,300,837
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2026 and December 31, 2025 0 0
Common stock, $0.001 par value; 500,000,000 and 100,000,000 shares authorized; 132,032,636 and 131,691,237 shares issued and outstanding (including 0 and 4,149,252 contingently issuable shares - see Note 10) at March 31, 2026 and December 31, 2025, respectively 132,032 131,691
Additional paid-in capital 326,575,169 315,429,986
Accumulated other comprehensive income (loss) (26,293) 21,802
Accumulated deficit (159,060,640) (142,679,800)
Total stockholders' equity 167,620,268 172,903,679
Total liabilities and stockholders' equity $ 173,332,227 $ 181,204,516